The Role of Polyvascular Disease in Cardiovascular Risk
Polyvascular disease, defined as the involvement of multiple vascular territories, has emerged as a key indicator of elevated cardiovascular risk. This deep dive examines its implications and management.
In this seriesTopic Deep Dives4
What is the significance of polyvascular disease in the context of cardiovascular risk assessment?
Introduction
Polyvascular disease encompasses atherosclerotic involvement in two or more vascular territories—typically illustrating combined coronary artery disease (CAD), peripheral artery disease (PAD), and cerebrovascular conditions. Its identification is crucial, given its association with a markedly elevated risk of cardiovascular events.
Epidemiological Insights
Recent studies, including data from the XATOA registry, underscore that patients with polyvascular disease experience significantly higher incidences of major adverse cardiovascular events (MACE) and limb complications. Among nearly 5,532 patients in the XATOA study, the incidence rate of MACE or major adverse limb events (MALE) in patients with polyvascular disease was 9.16 per 100 patient-years, compared to 2.48 per 100 patient-years in those without.
Clinical Implications
Identifying polyvascular disease allows healthcare professionals to stratify risk and tailor treatment plans accordingly. Those with polyvascular disease should be considered for more aggressive treatment strategies, including dual antithrombotic therapy—such as low-dose rivaroxaban and aspirin—due to their exceptional risk of event recurrence.
Treatment Considerations
The management of patients with polyvascular disease should also consider co-morbidities prevalent in this cohort, including diabetes, heart failure, and chronic renal insufficiency, all of which further compound cardiovascular risk. This necessitates an integrated care approach that ensures coordination across specialties.
Conclusion
Polyvascular disease serves as a critical determinant of cardiovascular risk that requires vigilant assessment and management tailored to the individual’s complete clinical profile. As highlighted in the XATOA registry, carefully identifying and managing these patients can potentially alter their clinical trajectory.